1-{6-[(6-allyl-5,5-dioxido-6H-pyrido[2,3-c]pyrimido[4,5-e][1,2]thiazin-2-yl)amino]-2,3-dihydro-1H-indol-1-yl}ethanone | 1418315-17-9

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 二嗪类
• 英文名称: 1-{6-[(6-allyl-5,5-dioxido-6H-pyrido[2,3-c]pyrimido[4,5-e][1,2]thiazin-2-yl)amino]-2,3-dihydro-1H-indol-1-yl}ethanone
• 英文别名: 1-[6-[(8,8-Dioxo-9-prop-2-enyl-8lambda6-thia-3,5,9,11-tetrazatricyclo[8.4.0.02,7]tetradeca-1(10),2,4,6,11,13-hexaen-4-yl)amino]-2,3-dihydroindol-1-yl]ethanone；1-[6-[(8,8-dioxo-9-prop-2-enyl-8λ6-thia-3,5,9,11-tetrazatricyclo[8.4.0.02,7]tetradeca-1(10),2,4,6,11,13-hexaen-4-yl)amino]-2,3-dihydroindol-1-yl]ethanone
• CAS: 1418315-17-9
• 化学式: C₂₂H₂₀N₆O₃S
• 分子量: 448.505
• InChiKey: QFCMPZYSZKDCKX-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.8
• 重原子数：
  32
• 可旋转键数：
  4
• 环数：
  5.0
• sp3杂化的碳原子比例：
  0.18
• 拓扑面积：
  117
• 氢给体数：
  1
• 氢受体数：
  8

文献信息

• New Chemical Entities To Be Used For Wee1 Inhibition For The Treatment Of Cancer
  申请人：Woods Keith W.

  公开号：US20130018045A1

  公开（公告）日：2013-01-17

  The present invention relates to compounds of formula (I) or pharmaceutical acceptable salts, wherein R 1 , R 2 , R 3 , A, B, and n are defined in the description. The present invention relates also to compositions containing said compounds which are useful for inhibiting kinases such as wee-1 and methods of treating diseases such as cancer.
• US8716297B2
  申请人：——

  公开号：US8716297B2

  公开（公告）日：2014-05-06